Founded in
2020
SHORT DESCRIPTION:
Montis Biosciences is develops novel immune-oncology therapeutics targeting the intersection between vascular dysfunction and immune suppression to treat solid tumours.
LONG DESCRIPTION:
Meise
2020
$ 5 Millions - $ 10 Millions
Add a review